BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Pierre Fabre Medicament 

Parc Industriel de la Chartreuse

Castres Cedex    81106  France
Phone: 33-0-5-63-71-45-00 Fax:


SEARCH JOBS




Industry
Biotechnology






 Company News
Forest Laboratories, Inc. (FRX) and Pierre Fabre Medicament Announce Third Positive Phase III Study for Levomilnacipran in Patients With Major Depressive Disorder 4/26/2012 7:28:32 AM    More...
Forest Laboratories, Inc. (FRX) and Pierre Fabre Medicament Announce Positive Phase III Results For Levomilnacipran in Patients With Major Depressive Disorder 3/7/2012 7:28:59 AM    More...
Pierre Fabre Medicament is Granted Authorization in Australia to Market the Milnacipran JONCIA(R) to Treat Fibromyalgia 11/21/2011 11:56:20 AM    More...
Forest Laboratories, Inc. (FRX), Pierre Fabre Medicament Announce Positive Phase III Results with Levomilnacipran in Patients with Major Depressive Disorder 7/18/2011 6:32:52 AM    More...
Pierre Fabre Medicament And Zambon Sign Commercial Agreement In Germany 2/21/2007 5:14:34 PM    More...
Novacea And Pierre Fabre Medicament Enter Into Partnership For The Development And Commercialization Of Oral Vinorelbine For Oncology 10/19/2005 5:12:09 PM    More...
Pierre Fabre Medicament And Merck & Co. (MRK) Sign Oncology Research Partnership And Licensing Agreement 10/19/2005 5:11:19 PM    More...
Bristol-Myers Squibb Company (BMY) And Pierre Fabre Medicament Enter Into Agreement To Develop And Commercialize Oncology Treatment Javlor(R) (vinflunine) 10/19/2005 5:10:57 PM    More...
Cypress Bioscience Inc., (CYPB) Forest Laboratories, Inc. (FRX) And Pierre Fabre Medicament Announce Development And Marketing Agreement For Milnacipran 10/19/2005 5:09:39 PM    More...